Back to Search
Start Over
Azathioprine-induced Myelotoxicity after Switching Mesalazine Compound
- Source :
- Inflammatory Bowel Diseases, 27(9), E114-E115. John Wiley and Sons Inc., Barnhoorn, M C, Storm, B N, de Boer, N K & van der Voorn, M M P J A 2021, ' Azathioprine-induced Myelotoxicity after Switching Mesalazine Compound ', Inflammatory Bowel Diseases, vol. 27, no. 9, pp. E114-E115 . https://doi.org/10.1093/ibd/izab102, Inflammatory Bowel Diseases
- Publication Year :
- 2021
- Subjects :
- medicine.medical_specialty
Ibdjnl/9
Azathioprine
Inflammatory bowel disease
Gastroenterology
chemistry.chemical_compound
Mesalazine
inflammatory bowel disease
Internal medicine
medicine
Humans
Immunology and Allergy
Letters to the Editor
Mesalamine
AcademicSubjects/MED00260
drug interaction
thiopurines
Drug Substitution
business.industry
Drug interaction
Inflammatory Bowel Diseases
medicine.disease
chemistry
mesalazine
business
Immunosuppressive Agents
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 10780998
- Volume :
- 27
- Issue :
- 9
- Database :
- OpenAIRE
- Journal :
- Inflammatory Bowel Diseases
- Accession number :
- edsair.doi.dedup.....40dfd467839bf0c98f21803516947ba5
- Full Text :
- https://doi.org/10.1093/ibd/izab102